“She is undoubtedly the only known case in the world,” said Thierry Peyrard, a medical biologist at Établissement français du ...

The discovery was officially recognised earlier this month in Milan by the International Society of Blood Transfusion. The ...

Does having a certain blood type really increase your risk of stomach cancer? According to a recent study, if you have these ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

A minor blood group incompatibility with anti-c caused severe hemolytic disease of the fetus and newborn even without ABO or ...

for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies. These products are gene therapies currently approved to treat blood cancers, such as ...

Cell and gene therapy leaders say the agency’s decision to remove the Risk Evaluation and Mitigation Strategies that had been ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

Antigen-presenting cells (APCs) are a heterogeneous group of immune cells that mediate the cellular immune response by processing and presenting antigens for recognition by certain lymphocytes ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.